Cresilon

Cresilon

Private
Brooklyn, New YorkHealthcare & Life Scienceshttps://www.cresilon.com

Last Round

Seed Round

Apr 29, 2026

Total Funding Raised

$77.19M

Momentum Score

25 /100

Company Overview

Cresilon is a medical technology company that develops hemostatic products made from plant-based polymers to support natural clotting and enhance wound healing by rapidly adhering to wounds and creating a mechanical barrier to control bleeding.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

hemostatic gelhemostatic devicebleeding controlplant-based hemostatVETIGELTRAUMAGELstop the bleedtrauma careblood clotting gelveterinary hemostathydrogel dressinghemostatic agentwound careanimal healthFDA clearedbattlefield medicineemergency medical servicesEMSmedical device manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cresilon Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cresilon Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 29, 2026
VC RoundSep 9, 2025
Series AOct 27, 2022
Series A ExtensionApr 8, 2021
Series A ExtensionJan 22, 2019
Series A
Jan 12, 2018

Key People

Founding team and executive leadership

David Sigona MCGI

Director Of Security (CEO Board), Buisness Development Consultant - SME Military Pre Hospital Emergency Care

Executive Team

Joe Landolina

Chief Executive Officer And Co-Founder

Founding Team

Hassaan Ahmad

Chief Operating Officer

Executive Team

Cresilon Investors

Notable investors and investment history

InvestorRounds
Paulson Investment CompanySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2026

    Raised $5M in seed funding.

  • Mar 25, 2026

    Named to Fast Company's Most Innovative Companies list, #1 in medical devices.

Cresilon Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cresilon Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cresilon's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrooklyn, New York
Employee Range95
Year Founded2010
Last FundingApr 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.